Tag: Mark Durkan

  • Mark Durkan – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    Mark Durkan – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Mark Durkan on 2015-11-24.

    To ask the Secretary of State for Business, Innovation and Skills, what steps he is taking to promote the development of a bio-plastics industry within a UK circular economy; and what the implications for his policy are of the effect of the EU’s Europe 2020 programme in supporting that sector at a regional level.

    Joseph Johnson

    The Government recognises the potential for the bio-plastics sector to contribute to a circular economy. The Department for Business, Innovation and Skills (BIS) is engaged with a range of businesses in the bio plastic industry including via the Bio-based and Biodegradable Industries Association and is working to help promote the potential growth of that sector. The EU 2020 strategy and the funding programmes that support that initiative offer opportunities for the UK. BIS is actively promoting and facilitating engagement and participation in the Horizon 2020 Programme via the Knowledge Transfer Network (KTN).

  • Mark Durkan – 2016 Parliamentary Question to the Department of Health

    Mark Durkan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Durkan on 2016-02-24.

    To ask the Secretary of State for Health, what steps his Department is taking to encourage routine use of NHS medicines throughout the NHS.

    George Freeman

    The Government is committed to ensuring that patients have access to new and effective treatments on terms that represent value to the National Health Service and the taxpayer.

    The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance, ensuring consistent access to clinically and cost effective drugs across England.

    The Accelerated Access Review, chaired by Sir Hugh Taylor, will make recommendations to government later this spring on reforms to accelerate access for NHS patients to innovative medicines, medical technologies, diagnostics and digital products.

  • Mark Durkan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Mark Durkan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Mark Durkan on 2016-05-03.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what steps the Government is taking to support the preservation of cultural sites in Sudan.

    James Duddridge

    The UK Government is not directly involved in the preservation of cultural sites in Sudan. However, the British Council has previously sought to increase the awareness and appreciation of Sudan’s cultural heritage, including its cultural sites, amongst Sudanese youth. In addition, the British Museum has long-been involved in the archaeology of Sudan, including the preservation of cultural sites in Sudan, often with the support of the British Council.

  • Mark Durkan – 2016 Parliamentary Question to the HM Treasury

    Mark Durkan – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Mark Durkan on 2016-09-02.

    To ask Mr Chancellor of the Exchequer, if he plans to introduce a MP hotline number for Concentrix.

    Mr David Gauke

    I refer the Right Honourable gentleman to the answer I gave on 1 December 2015 (17151).

  • Mark Durkan – 2016 Parliamentary Question to the HM Treasury

    Mark Durkan – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Mark Durkan on 2016-10-20.

    To ask Mr Chancellor of the Exchequer, how many tax credit claims classed as high risk renewals by HM Revenue and Customs have been referred to Concentrix in each of the three risk categories.

    Jane Ellison

    Between 1 August 2016 and 31 August 2016 HM Revenue and Customs (HMRC) automatically stopped 365,483 tax credit claims as a direct result of customers failing to comply with the requirements of the annual renewal process.

    Alongside the annual renewal process, HMRC records the number of awards that have been amended, which could be stopped, reduced or increased. Therefore, data showing the total number of claims stopped following a compliance intervention is unavailable.

    During the course of the contract, HMRC delegated a total caseload of 2,209,500 cases for high risk renewal checks by Concentrix. Of these 1,635,676 cases were not the subject of further investigation for fraud or error by Concentrix. This amounts to 74% of the total caseload.

    The volume of high risk renewals referred to Concentrix are broken down into the three risk categories as follows:

    • Undeclared Partner: 1,398,908

    • Work & Hours: 564,983

    • Child Care: 245,609

  • Mark Durkan – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    Mark Durkan – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Mark Durkan on 2015-11-24.

    To ask the Secretary of State for Business, Innovation and Skills, if he will make an assessment of the implications for his policies of the finding in the report, The future potential economic impacts of a bio-plastics industry in the UK, published by the Bio-based and Biodegradable Industries Association in October 2015, that, given the correct legislative environment, a UK bioplastics industry could support 35,000 jobs and contribute £1.9 billion to the economy.

    Joseph Johnson

    I note the report by the Bio-based and Biodegradable Industries Association into the future potential impacts of a bio-plastics industry in the UK.

    The Government delivers a range of policies across the business landscape – including research funding and innovation – that will be helpful in supporting the development of this sector. At the recent Autumn Statement, it was confirmed that science funding of £4.7 billion will be protected in real terms over the Parliament, and we will protect the Catapult network to support innovative firms and sectors.

  • Mark Durkan – 2016 Parliamentary Question to the Department of Health

    Mark Durkan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Durkan on 2016-02-24.

    To ask the Secretary of State for Health, if his Department, NHS England and NICE will publish work undertaken to analyse variation between areas in treatment for patients during the transition from the current Cancer Drugs Fund (CDF) to proposed a new CDF scheme.

    George Freeman

    NHS England has advised that it plans to publish analyses of variation in use of Cancer Drug Fund (CDF) drug indications according to geographical areas in the spring of 2016 and then routinely in the future for the new CDF.

  • Mark Durkan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Mark Durkan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Mark Durkan on 2016-05-18.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, whether his Department has made representations to the Iranian government on the continued detention of seven Bahá’í leaders.

    Mr Tobias Ellwood

    The UK regularly raises our concerns at the treatment of the Baha’i community in Iran. We call on Iran to cease harassment of all religious minorities and to fulfil its international and domestic obligations to allow freedom of religion to all Iranians.

  • Mark Durkan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Mark Durkan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Mark Durkan on 2016-10-07.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, how many UK citizens are known to have been (a) detained and (b) delayed when entering Israel in the past 12 months.

    Mr Tobias Ellwood

    ​According to Israeli figures 129 000 British nationals have visited Israel since 1 January 2016, and 50 British nationals have been refused entry into Israel through Ben-Gurion Airport. Of these, 25 sought assistance from the British Embassy. A further 65 British nationals have been refused entry at the Allenby Bridge.

  • Mark Durkan – 2016 Parliamentary Question to the Department for International Development

    Mark Durkan – 2016 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by Mark Durkan on 2016-10-20.

    To ask the Secretary of State for International Development, how much funding from the public purse the UK will contribute to the Better Migration Management programme.

    Rory Stewart

    The €46 million ‘Better Migration Management’ programme is part of the EU’s joint work on addressing unmanaged flows from Africa under the Horn of Africa component of the €1.9 billion EU Emergency Trust Fund for Africa. The UK has made no direct financial contribution to this programme. However, we have committed to a contribution of €3 million to the Horn of Africa component of the Trust Fund overall. That is in addition to the UK’s underlying contribution to the Trust Fund, which amounts to approximately 15% of the EU’s total €1.8 billion contribution, predominantly drawn from the European Development Fund.